Overview
Peng Song practices in Beijing, China. Mr. Song is rated as a Distinguished expert by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Lung Adenocarcinoma, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Esophageal Cancer.
His clinical research consists of co-authoring 79 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 24 articles in the study of Lung Adenocarcinoma.
Locations
Xinkai, China
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Lung AdenocarcinomaMr. Song isDistinguished. Learn about Lung Adenocarcinoma.
- Advanced
- Lung CancerMr. Song isAdvanced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Experienced
- Adenoid Cystic CarcinomaMr. Song isExperienced. Learn about Adenoid Cystic Carcinoma.
- Esophageal CancerMr. Song isExperienced. Learn about Esophageal Cancer.
- FibrosarcomaMr. Song isExperienced. Learn about Fibrosarcoma.
- Low Blood PressureMr. Song isExperienced. Learn about Low Blood Pressure.
- Malignant Peripheral Nerve Sheath Tumor
- Neuroendocrine TumorMr. Song isExperienced. Learn about Neuroendocrine Tumor.